Infinity Pharmaceuticals | INFI - Выручка от реализации





Продажи Изменить Дата
AbbVie USD 15B 1.62B 2026-03
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Amgen USD 8.62B 1.28B 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Cipla INR 65.41B 9.77B 2026-03
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 6.35M 60.98M 2026-03
CSL USD 8.33B 4.79B 2025-12
Eisai JPY 205.43B 14.51B 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Grifols EUR 2B 306.7M 2026-03
Incyte USD 1.27B 240M 2026-03
Infinity Pharmaceuticals USD 583K 148K 2023-06
Ionis Pharmaceuticals USD 246M 43M 2026-03
J&J USD 24.1B 500M 2026-03
Novartis USD 13.11B 226M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Plus Therapeutics USD 1.37M 30K 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
TG Therapeutics USD 194.8M 2.23M 2026-03